Professor Giuseppe Rosano discusses "True advances in the treatment of heart failure" at the 2015 ESC congress in London.
1. In your view, what are the true advances in the management of heart failure?
2. Of the new therapeutic agents, which, in your view, are more likely to make a difference in terms of survival and hospitalisations?
3. Do oestrogen and testosterone play any role in the management of angina pectoris? And what is the evidence?